this underperformed pharma stock is trading well below its all time high. Could not rally last time after good quarterly result. it appears its break out is taking place slow and steadily. It is a f&o stock hence not a study on f&o perceptive. Target has been achieved Target 4 may be achieved in due course. don't forget to like my post. follow me to get updates
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.